Fig. 3.

IMB17–15 administration shifted the hepatic and serum BA compositions in hamsters. Hepatic BA composition (a) and serum BA composition (b) (ACA Allocholic acid, CA cholic acid, CDCA chenodeoxycholic acid, DCA deoxycholic acid, GCA glycocholic acid, HDCA α-hyodeoxycholic acid, LCA lithocholic acid, TCA taurocholic acid, TCDCA taurocheno-deoxycholic acid, TDCA taurodeoxycholic acid, THDCA taurohyodeoxycholic acid, TLCA taurolithocholic acid, TUDCA tauroursodeoxycholic acid, TαMCA tauro α-muricholate, TβMCA tauro β-muricholate, UDCA ursodeoxycholic acid, αMCA α-muricholic acid, βMCA β-muricholic acid). The labeling scheme for each group is indicated in the embedded legend. The means ± SD are shown. ^#P < 0.05 versus the control group, *P < 0.05 versus the HFD+NS group; ANOVA followed by Tukey’s test